ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1448

Progressive Pseudorheumatoid Arthropathy of Childhood (PPAC)  – a Single Center Case Series

Renate Haefner, Boris Huegle and Johannes Peter Haas, German Center for Pediatric and Adolescent Rheumatology, Garmisch-Partenkirchen, Germany

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: bone disease and genetic disorders

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects Posters. Juvenile Arthritis and Miscellaneous Rheumatic Diseases

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:   Progressive pseudorheumatoid arthropathy of childhood (PPAC, OMIM #208230) is a bone dysplasia caused by mutations in the WISP3 gene. Due to its presentation with joint stiffness and finger swelling, it is frequently misdiagnosed as polyarticular juvenile idiopathic arthritis (JIA). However, PPAC has some characteristics which distinguish it from JIA; early diagnosis avoids unnecessary treatments and allows adequate therapy for an optimum long-term outcome.

The objective of this study was to retrospectively document a single center cohort of PPAC and describe presentation and clinical course of this rare disease.

Methods: The database of the German Center for Pediatric and Adolescent Rheumatology was searched to identify all patients with a diagnosis of PPAC seen between 1997 and 2015. Clinical and molecular genetic data was extracted from patient files, and results were analyzed using descriptive statistics.                                                               

Results: 8 patients were included (6 male, 2 female), including 2 sibling pairs. Median age at presentation was 8 years (range 6 – 13 years), median follow-up was 8.5 years (range 3 – 18 years). Median age of first symptoms was 3 years (range 1 – 4 years). Four patients (50 %) were diagnosed as JIA prior to diagnosis of PPAC. Mutations in the WISP3 gene were detected in 5/5 tested patients. Typical symptoms at onset were abnormal gait (7/8 patients), swelling of the interphalangeal finger joints (4/8 patients) and muscular weakness (2/8 patients). All patients developed short stature with height below the 3rd percentile and an abnormally short trunk, mainly due to vertebral dysplasia which became apparent during elementary school in most cases. Other radiographic abnormalities included overgrowth of the epiphyses (8/8 patients), widening of the heads of the basal phalanges (8/8 patients) and malformation of vertebral bodies (8/8 patients). Functional impairment progressed in all cases, with severely impaired ambulation on last follow-up. Two patients regained longer walking distances after joint replacement of the hips, one patient also received knee arthroplasty. Avascular necrosis developed in 5/8 patients, involving the femoral head, the proximal tibia and the talus bone.

Conclusion: PPAC is frequently misdiagnosed as JIA, but history, typical symptoms and radiographs of the hands and spine can help to differentiate the two disease entities. Patients uniformly develop short stature and are at risk for avascular necrosis. Joint replacements can significantly improve function.


Disclosure: R. Haefner, None; B. Huegle, None; J. P. Haas, None.

To cite this abstract in AMA style:

Haefner R, Huegle B, Haas JP. Progressive Pseudorheumatoid Arthropathy of Childhood (PPAC)  – a Single Center Case Series [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/progressive-pseudorheumatoid-arthropathy-of-childhood-ppac-a-single-center-case-series/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/progressive-pseudorheumatoid-arthropathy-of-childhood-ppac-a-single-center-case-series/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology